Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac versus ketamine for postoperative analgesia after lumbar fusion using PCA
IRCT20160403027191N5Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain and postoperative nausea and vomiting (PONV) comparing Ketamine PCA arm, Ketorolac PCA arm and Morphine PCA control arm (3 arms). Primary endpoints: Pain intensity and Nausea and vomiting. Started Nov 2023; status: completed.
02
Drugs
ketamineketorolacmorphine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20160403027191N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160403027191N5.